Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell ...
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized ...
Money.ca on MSN
Stem-cell tourism is costing Canadians tens of thousands — and more, especially when multiple risks can outweigh the results
From TikTok testimonials to $30,000 trips abroad, more Canadians are chasing experimental treatments that Health Canada ...
The planet is getting hotter, and life will need to adapt to rising temperatures to survive. One way cells adapt to changing ...
Mast cell biology spans immunology, inflammation, and tissue homeostasis. Traditionally viewed as principal effectors of IgE-mediated allergic reactions, ...
A study in mice and in human cells by Stanford Medicine researchers has linked organ aging to the increased inabilityw ...
Researchers at the Icahn School of Medicine at Mount Sinai have identified the immune cell that acts as the architect and coordinator of powerful immune hubs that form inside tumors and plays a key ...
We may age at different rates, but none of us escapes aging. A study in mice and in human cells by Stanford Medicine ...
Poised to become the first company to achieve a regulatory filing for a cell therapy in autoimmune disease, Kyverna Therapeutics is building a pipeline-in-a-product to change the treatment paradigm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results